Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Iliad Trial: Low-dose Proleukin in Metastatic Renal Cell Carcinoma
NCT00006864Phase 4Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jul 2000
- Primary completion
- Jul 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of aldesleukin in renal cell carcinoma (RCC), sponsored by Case Comprehensive Cancer Center. Started Jul 2000; status: completed.
02
Drugs
aldesleukin
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00006864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006864.